Literature DB >> 21576412

MMP2 gene polymorphisms and MMP2 mRNA levels in patients with superficial varices of lower extremities.

Uzay Görmüş1, Ozlem Timirci Kahraman, Selim Isbir, Atike Tekeli, Turgay Isbir.   

Abstract

BACKGROUND: Although superficial varices of lower extremities with high morbidity are common, their etiology has not been elucidated yet. Previously, it was thought that venous hypertension was responsible for such cases by causing valvular insufficiency, but recent findings indicate that the changes in the venous wall structure might be main initiating factors. Matrix metalloproteinase enzyme-2 (MMP2) is one of the enzymes known to have functions in remodelling of the extracellular matrix mainly in vascular structures.
MATERIALS AND METHODS: We studied two functional gene polymorphisms in -735 and -1306 regions of matrix metalloproteinase enzyme-2 (MMP2) gene, and their effects on mRNA expression of MMP2. We used a previously defined (PCR-RFLP) method for polymorphism analyses.
RESULTS: CC genotype and C allele for MMP2 -735 gene region were more common in the control group and there was no significant difference between groups for MMP2 - 1306 gene polymorphisms. MMP2 mRNA levels were higher in the group that had both varices and coronary artery disease (CAD).
CONCLUSION: There was no significant effect of MMP2 polymorphisms on mRNA expression. As MMP2 mRNA levels were higher in varices patients with CAD compared to the CAD only and varices only groups, it is necessary to make advanced researches to elucidate the relationship between CAD and varices.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21576412

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  1 in total

1.  HFE p.C282Y gene variant is associated with varicose veins in Russian population.

Authors:  Ekaterina A Sokolova; Alexandra S Shadrina; Kseniya S Sevost'ianova; Andrey I Shevela; Evgenii Yu Soldatsky; Evgenii I Seliverstov; Marina Yu Demekhova; Oleg A Shonov; Evgenii A Ilyukhin; Mariya A Smetanina; Elena N Voronina; Igor A Zolotukhin; Maxim L Filipenko
Journal:  Clin Exp Med       Date:  2015-09-28       Impact factor: 3.984

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.